53 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
of $0.0001 per share of common stock, subject to beneficial ownership limitations). The holders of a majority in voting power of the shares of common stock … , the affirmative vote of the majority of votes cast affirmatively or negatively (excluding abstentions) is required for approval. This is a routine proposal so we do
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
Exchange.
A significant majority of our employees’ and directors’ options outstanding under the 2020 Plan have exercise prices that exceed, in some cases
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
value of the Eligible Options that are surrendered in the Option Exchange.
A significant majority of our employees’ and directors’ options have … Exchange.
A significant majority of our employees’ and directors’ options have exercise prices that exceed, in some cases significantly, the trading prices
424B3
t5lepw9g 9ck
28 Nov 23
Prospectus supplement
4:01pm
8-K
EX-10.1
mmbqde
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-99.1
fv4kix9 80
3 Aug 23
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
zh9vyhkz5nu
4 May 23
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2023 Financial Results
4:05pm
S-3
EX-4.4
sij6s01s
4 Nov 21
Shelf registration
4:57pm